Leflunomide-induced Stevens Johnson syndrome in a patient with systemic lupus erythematosus

[1]  F. Sánchez‐Madrid,et al.  Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway , 2008, Annals of the rheumatic diseases.

[2]  Somaya Safi,et al.  Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis. , 2008, Joint, bone, spine : revue du rhumatisme.

[3]  A. Kermode,et al.  Leflunomide-induced peripheral neuropathy , 2007, Journal of Clinical Neuroscience.

[4]  Y. Teraki,et al.  Leflunomide‐induced toxic epidermal necrolysis , 2006, International journal of dermatology.

[5]  G. Parthasarathi,et al.  Severe cutaneous adverse drug reaction to leflunomide: a report of five cases. , 2006, Indian journal of dermatology, venereology and leprology.

[6]  M. Iwamoto,et al.  Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. , 2004, Internal medicine.

[7]  D. Loeuille,et al.  Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[8]  E. Rivarola de Gutierrez,et al.  Photodistributed Lichenoid Drug Eruption with Rhabdomyolysis Occurring during Leflunomide Therapy , 2004, Dermatology.

[9]  E. Hachulla,et al.  Toxidermie lichénoïde au léflunomide (Arava). , 2003 .

[10]  E. Balslev,et al.  Vasculitis Occurring during Leflunomide Therapy , 2001, Dermatology.

[11]  D. Wallace,et al.  Benefyts of lefiunomide in systemic lupus erythematosus: a pilot observational study , 2001, Lupus.

[12]  S. Manna,et al.  Leflunomide Suppresses TNF-Induced Cellular Responses: Effects on NF-κB, Activator Protein-1, c-Jun N-Terminal Protein Kinase, and Apoptosis1 , 2000, The Journal of Immunology.

[13]  P. Knoflach,et al.  Severe pancytopenia after leflunomide in rheumatoid arthritis. , 2000, Acta medica Austriaca.

[14]  P. Emery,et al.  Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story. , 2000, Rheumatology.

[15]  V. Strand,et al.  Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. , 1999, Archives of internal medicine.

[16]  J. Smolen,et al.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial , 1999, The Lancet.

[17]  B. Fernández-Gutiérrez,et al.  Leflunomide-induced acute hepatitis. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[18]  E. Hachulla,et al.  [Lichenoid drug reaction to leflunomide]. , 2003, Annales de dermatologie et de venereologie.

[19]  G. Wahl,et al.  Mechanism of action for leflunomide in rheumatoid arthritis. , 1999, Clinical immunology.

[20]  R. Bartlett,et al.  Development of autoimmunity in MRL/lpr mice and the effects of drugs on this murine disease. , 1988, Scandinavian journal of rheumatology. Supplement.